Theo dõi
Hani Al-Salami
Hani Al-Salami
Biotechnology and Drug Development Research Laboratory, Curtin Medical School and CHIRI, Curtin
Email được xác minh tại curtin.edu.au
Tiêu đề
Trích dẫn bởi
Trích dẫn bởi
Năm
Inflammatory bowel disease: clinical aspects and treatments
M Fakhoury, R Negrulj, A Mooranian, H Al-Salami
Journal of inflammation research, 113-120, 2014
6392014
Microparticles, microcapsules and microspheres: A review of recent developments and prospects for oral delivery of insulin
CY Wong, H Al-Salami, CR Dass
International journal of pharmaceutics 537 (1-2), 223-244, 2018
2742018
Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles
N Pavlović, S Goločorbin-Kon, M Ðanić, B Stanimirov, H Al-Salami, ...
Frontiers in Pharmacology 9, 1283, 2018
2682018
Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment
CY Wong, H Al-Salami, CR Dass
Journal of controlled release 264, 247-275, 2017
2302017
Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats
H Al-Salami, G Butt, JP Fawcett, IG Tucker, S Golocorbin-Kon, M Mikov
European journal of drug metabolism and pharmacokinetics 33, 101-106, 2008
1862008
Oral insulin delivery: existing barriers and current counter-strategies
A Gedawy, J Martinez, H Al-Salami, CR Dass
Journal of pharmacy and pharmacology 70 (2), 197-213, 2018
1612018
Blood-brain barrier dysfunction precedes cognitive decline and neurodegeneration in diabetic insulin resistant mouse model: an implication for causal link
R Takechi, V Lam, E Brook, C Giles, N Fimognari, A Mooranian, ...
Frontiers in aging neuroscience 9, 399, 2017
1552017
A systematic review of the valproic-acid-induced rodent model of autism
D Chaliha, M Albrecht, M Vaccarezza, R Takechi, V Lam, H Al-Salami, ...
Developmental neuroscience 42 (1), 12-48, 2020
1432020
Molecular mechanism of action and pharmacokinetic properties of methotrexate
V Maksimovic, Z Pavlovic-Popovic, S Vukmirovic, J Cvejic, A Mooranian, ...
Molecular biology reports 47, 4699-4708, 2020
1432020
Pharmacological applications of bile acids and their derivatives in the treatment of metabolic syndrome
M Ðanić, B Stanimirov, N Pavlović, S Goločorbin-Kon, H Al-Salami, ...
Frontiers in pharmacology 9, 1382, 2018
1362018
Development and validation of a new analytical HPLC method for simultaneous determination of the antidiabetic drugs, metformin and gliclazide
A Gedawy, H Al-Salami, CR Dass
journal of food and drug analysis 27 (1), 315-322, 2019
1072019
The influence of intestinal tract and probiotics on the fate of orally administered drugs
M Stojančević, G Bojić, H Al Salami, M Mikov
Current issues in molecular biology 16 (1), 55-68, 2014
1072014
C2C12 cell model: its role in understanding of insulin resistance at the molecular level and pharmaceutical development at the preclinical stage
CY Wong, H Al-Salami, CR Dass
Journal of Pharmacy and Pharmacology 72 (12), 1667-1693, 2020
1012020
Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus
CY Wong, H Al-Salami, CR Dass
International journal of pharmaceutics 549 (1-2), 201-217, 2018
992018
Influence of the semisynthetic bile acid MKC on the ileal permeation of gliclazide in vitro in healthy and diabetic rats treated with probiotics.
H Al-Salami, G Butt, I Tucker, M Mikov
Methods and findings in experimental and clinical pharmacology 30 (2), 107-113, 2008
792008
Antimicrobial efficacy of nisin-loaded bacterial cellulose nanocrystals against selected meat spoilage lactic acid bacteria
STG Gedarawatte, JT Ravensdale, H Al-Salami, GA Dykes, R Coorey
Carbohydrate Polymers 251, 117096, 2021
782021
Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol
A Mooranian, R Negrulj, N Chen-Tan, HS Al-Sallami, Z Fang, TK Mukkur, ...
Drug design, development and therapy, 1221-1230, 2014
782014
Probiotic Pre‐treatment Reduces Gliclazide Permeation (ex vivo) in Healthy Rats but Increases It in Diabetic Rats to the Level Seen in Untreated Healthy Rats
H Al‐Salami, G Butt, I Tucker, R Skrbic, S Golocorbin‐Kon, M Mikov
Archives of drug information 1 (1), 35-41, 2008
782008
Applications of superparamagnetic iron oxide nanoparticles in drug and therapeutic delivery, and biotechnological advancements
M Suciu, CM Ionescu, A Ciorita, SC Tripon, D Nica, H Al-Salami, ...
Beilstein Journal of Nanotechnology 11 (1), 1092-1109, 2020
762020
Stability and release kinetics of an advanced gliclazide-cholic acid formulation: the use of artificial-cell microencapsulation in slow release targeted oral delivery of …
A Mooranian, R Negrulj, S Mathavan, J Martinez, J Sciarretta, ...
Journal of pharmaceutical innovation 9, 150-157, 2014
712014
Hệ thống không thể thực hiện thao tác ngay bây giờ. Hãy thử lại sau.
Bài viết 1–20